気腫(Emphysema):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Emphysema - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
気腫(Emphysema):治療薬開発パイプライン動向(2015年上半期版) (Code:GMDHC6434IDB)

【レポートの概要(一部)】

Emphysema – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Emphysema – Pipeline Review, H1 2015’, provides an overview of the Emphysema’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Emphysema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emphysema and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global therapeutic landscape of Emphysema
– The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved in the therapeutics development for Emphysema and enlists all their major and minor projects
– The report summarizes all the dormant and discontinued pipeline projects
– A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
– Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– A detailed assessment of monotherapy and combination therapy pipeline projects
– Coverage of the Emphysema pipeline on the basis of target, MoA, route of administration and molecule type
– Latest news and deals relating related to pipeline products

Reasons to buy

– Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop strategic initiatives by understanding the focus areas of leading companies
– Identify and understand important and diverse types of therapeutics under development for Emphysema
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Devise corrective measures for pipeline projects by understanding Emphysema pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

.....

【日本語概要(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポートの目次(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Emphysema Overview 6
Therapeutics Development 7
Pipeline Products for Emphysema – Overview 7
Pipeline Products for Emphysema – Comparative Analysis 8
Emphysema – Therapeutics under Development by Companies 9
Emphysema – Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Emphysema – Products under Development by Companies 12
Emphysema – Companies Involved in Therapeutics Development 13
Angion Biomedica Corp. 13
Boehringer Ingelheim GmbH 14
Intrexon Corporation 15
Protalix BioTherapeutics, Inc. 16
rEVO Biologics 17
Emphysema – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Combination Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
(olodaterol + tiotropium bromide) – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Alpha-1 Antitrypsin With rHuPH20 – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
BB-3 – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
EDO-66 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Monoclonal Antibody to Inhibit EMAP II for Emphysema – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
PRX-107 – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Recombinant Human Alpha-1 Antitrypsin – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
TRN-101 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Emphysema – Recent Pipeline Updates 39
Emphysema – Dormant Projects 42
Emphysema – Product Development Milestones 43
Featured News & Press Releases 43
Jun 20, 2013: Protalix BioTherapeutics Reveals Information For Emphysema Drug, PRX-107 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45

.....

【日本語目次(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポート販売概要】

■ タイトル:気腫(Emphysema):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Emphysema - Pipeline Review, H1 2015
■ 発行日:2015年3月19日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6434IDB
■ 調査対象地域:グローバル

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
気腫(Emphysema):治療薬開発パイプライン動向(2015年上半期版) (Emphysema - Pipeline Review, H1 2015 / GMDHC6434IDB)

  • 骨転移(Bone Metastasis):世界の治験レビュー(2015年上半期版)
    Bone Metastasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as …
  • フッ素系界面活性剤の世界市場予測(~2021年)
    “Fluorosurfactants market to grow at a CAGR of 9.8% during the forecast period”The fluorosurfactants market size is projected to reach USD 667.4 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Fluorosurfactants are recognized as synthetic organo-fluorine compounds with multiple fluorine atoms. Fluorosurfactants reduce the surface tension of organic or aqueous solutions and act as wetting, le …
  • 集団健康管理(PHM)の世界市場予測(~2021年)
    The population health management market is projected to reach USD 42.54 Billion by 2021 from USD 13.85 Billion in 2016, at a CAGR of 25.2% in the next five years (2016 to 2021). The implementation of the Affordable Care Act (ACA) in the U.S., government support for the prevention of diseases and adoption of HCIT, rising geriatric population and the subsequent increase in the prevalence of chronic …
  • フローズンヨーグルトの世界市場2016-2020
    About Frozen Yogurt Frozen yogurt is made with milk, sugar, and other ingredients such as corn syrup, yogurt cultures, and non-fat yogurt powder. It is enriched with probiotics and has low fat and sugar content. It is perceived as a nutritious and healthy alternative to desserts like ice cream. Technavio’s analysts forecast the global frozen yogurt market to grow at a CAGR of 20.49% during the per …
  • DONG Energy A/S:発電所及び企業SWTO分析2015
    DONG Energy A/S - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and det …
  • グルテンフリー食品の世界市場:グルテンフリーベーカリー、ピザ、パスタ、シリアル、菓子
    The gluten-free products market has been segmented on the basis of type, source, and region. The market for gluten-free products is projected to grow at a CAGR of 10.4% from 4.63 Billion in 2015 to reach USD 7.59 Billion in 2020. The gluten-free products market is segmented on the basis of type into bakery products, pizzas & pastas, cereals & snacks, savories, and others. In 2014, the global glute …
  • 小規模液化天然ガス(LNG)の世界市場:小規模再ガス化、小規模液化、LNGサテライトステーション、LNG積込設備、LNG燃料補給施設
    Visiongain identifies LNG import terminals and liquefaction plants as small scale if their regasification or liquefaction capacity is less than 1 mtpa. Other elements of the small scale LNG market are bunkering facilities used by LNG fuelled vessels, infrastructure to supply LNG as a fuel for road vehicles and LNG satellite stations. Historically, LNG is produced by large scale liquefaction plants …
  • 旅客情報システム(PIS)の世界市場2015-2019
    Covering: Market forecast and analysis of the global passenger information system market until 2019. Market size and segmentations by products (hardware, software, and services), and by mode of transport (roadways, airways, and railways). It includes market shares for APAC, Americas, and EMEA. Top vendors analyzed by this report include Alstom, Cubic Transportation, GE, Hitachi, and Huawei This re …
  • 超純水の世界市場:超純水装置/材料/サービス、超純水用途、地域別分析
    The ultrapure water market is projected to reach USD 7.15 Billion by 2020, at a CAGR of 7.8% between 2015 and 2020. The key factor driving this growth is its increased usage in the semiconductor manufacturing industry. The semiconductor industry contributed a major share in the ultrapure water market in 2015, due to the increased usage of ultrapure water in the wafer fabrication process and clean …
  • 公共交通機関向けLED照明の世界市場
    This is the ElectroniCast analysis and forecast of global market consumption of light emitting diode-based lamps and related devices used in public transportation vehicles. For the purposes of this study, ElectroniCast defines public transportation as a shared passenger transportation service, which is available for use by the general public. Public transportation vehicles, included in this study, …
  • 光ネットワーク及び光通信デバイスの世界市場:光ファイバー、光増幅器、光スイッチ、光スプリッター、光ファイバーサーキュレーター等
    Optical networking and communications for this market study is as follows, a type of communications network wherein data transmission occurs via light as optical or Infra-Red signals and optical components form the building blocks of the network. The market has been defined as the summation of hardware and services revenues. The study captures the industry trends in the optical networking and comm …
  • Deglutition Disorders:グローバル臨床試験レビューH1, 2013
    Deglutition Disorders Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Deglutition Disorders Global Clinical Trials Review, H1, 2013" provides data on the Deglutition Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Deglutition Disorders. It includes an overview of the trial numbers and the …
  • POC脂質検査の世界市場2017-2021
    ABSTRACTAbout POC Lipid Testing Point-of-care (POC) lipid testing is used to measure the lipid level of the blood at a convenient place near the patient. The test also measures high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglyceride level of the blood. POC tests help reduce the time between the diagnosis and treatment of a disease. They are antibody-based or mi …
  • 塩素酸ナトリウムの世界市場動向及び予測2015
    The present report is an essential resource for a one looking for detailed information on the world sodium chlorate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true i …
  • ナノセルロースの世界市場:セルロース・ナノクリスタル、セルロース・ナノフィブリル、セルロース・ナノ複合材料
    The nano cellulose market is estimated around $ 250 million in 2014, with the high share held by North America and Europe together. The global nano cellulose market by value is projected to grow at a CAGR of approximately 19% from 2014 to 2019. The high growth is forecasted to be in the North America and Europe due to rising advancements in the end industries such as paper and paper board, composi …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。